MARKET

AKESF

AKESF

Akeso
OTCPK
12.00
0.00
0.00%
Closed 15:36 06/09 EDT
OPEN
12.20
PREV CLOSE
12.00
HIGH
12.20
LOW
11.94
VOLUME
500
TURNOVER
6.05K
52 WEEK HIGH
22.70
52 WEEK LOW
10.80
MARKET CAP
11.05B
P/E (TTM)
-68.0658
1D
5D
1M
3M
1Y
5Y
1D
Guotai Haitong Keeps Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 3d ago
Akeso Sets 2026 AGM to Approve Accounts, Board Slate and Capital-Issuance Mandate
TipRanks · 4d ago
BOCOM International Holdings Company Keeps Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 5d ago
Jefferies Keeps Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 5d ago
Huatai Securities Remains a Buy on Akeso, Inc. (9926)
TipRanks · 6d ago
Bank of America Securities Reaffirms Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 6d ago
CLSA Sticks to Their Buy Rating for Akeso, Inc. (9926)
TipRanks · 6d ago
CICC Reaffirms Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 06/02 05:17
More
About AKESF
Akeso Inc is an investment holding company dedicated to the research, development, manufacturing and commercialization of antibody drugs that are affordable to patients worldwide. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The Company's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

Webull offers Akeso Inc stock information, including OTCPK: AKESF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKESF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKESF stock methods without spending real money on the virtual paper trading platform.